We found that increased expression of FRMD6 significantly inhibits GBM cell proliferation and invasion through Matrigel (Figure 2B–2D), suggesting that FRMD6 displays anti-GBM activity in vitro. This evidence concerns the gene FRMD6 and glioblastoma.